DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alphagan P (Brimonidine Ophthalmic) - Adverse Event Reports - Serious Event

 



Index of reports > Cases resulting in a serious event (5)

     Drug Ineffective (2)Intraocular Pressure Increased (2)Visual Acuity Reduced (2)Vision Blurred (2)Corneal Oedema (2)Palpitations (1)Retinal Disorder (1)Optic Nerve CUP / Disc Ratio Increased (1)Feeling Abnormal (1)Renal Failure Acute (1)

Below is the selection of adverse event reports related to Alphagan P (Brimonidine Ophthalmic) that includes cases resulting in a serious event.

Adverse event in female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a individual with unspecified qualification from United States on 2007-06-12

Patient: female, weighing 56.7 kg (124.7 pounds)

Adverse reactions / side effects: Tinnitus, Palpitations, Sensation of Pressure, Feeling Abnormal, Hypertension

Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)



Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from United States on 2007-05-08

Patient: male

Adverse reactions / side effects: Renal Failure Acute

Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)

Other drugs received by patient: Coumadin; Glucotrol; Lisinopril; Lantus; Bumex; Advair Diskus 100 / 50



Adverse event in 26 year old female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from Korea, Republic of on 2007-02-14

Patient: 26 year old female

Adverse reactions / side effects: Drug Ineffective, Intraocular Pressure Increased, Vision Blurred, Retinal Disorder, Optic Nerve CUP / Disc Ratio Increased, Condition Aggravated, Visual Acuity Reduced, Corneal Oedema

Adverse event resulted in: hospitalization

Suspect drug(s):
Cosopt
    Dosage: unk opht
    Indication: Developmental Glaucoma

Cosopt
    Dosage: unk opht
    Indication: Open Angle Glaucoma

Alphagan P
    Dosage: unk opht
    Indication: Developmental Glaucoma

Alphagan P
    Dosage: unk opht
    Indication: Open Angle Glaucoma

Xalatan
    Dosage: unk opht
    Indication: Developmental Glaucoma

Xalatan
    Dosage: unk opht
    Indication: Open Angle Glaucoma



Adverse event in 85 year old female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from United States on 2007-02-07

Patient: 85 year old female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Alphagan P
    Dosage: unk, bid
    Indication: Glaucoma
    Start date: 2006-10-06
    End date: 2007-01-22

Lumigan
    Indication: Glaucoma
    Start date: 2006-10-06
    End date: 2007-01-22



Adverse event in 26 year old female receiving Alphagan P (Brimonidine Ophthalmic)

Reported by a physician from Korea, Republic of on 2007-02-06

Patient: 26 year old female

Adverse reactions / side effects: Drug Ineffective, Intraocular Pressure Increased, Vision Blurred, Visual Acuity Reduced, Corneal Oedema

Adverse event resulted in: hospitalization

Suspect drug(s):
Cosopt
    Dosage: opht
    Indication: Developmental Glaucoma

Cosopt
    Dosage: opht
    Indication: Open Angle Glaucoma

Alphagan P
    Dosage: opht
    Indication: Developmental Glaucoma

Alphagan P
    Dosage: opht
    Indication: Open Angle Glaucoma

Xalatan
    Dosage: opht
    Indication: Developmental Glaucoma

Xalatan
    Dosage: opht
    Indication: Open Angle Glaucoma

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009